Creative Medical Technology Holdings Inc (CELZ)

[fly_fisherman]

HUGE POTENTIAL and M&A Heating UP ....


Finalizing an FDA study in Phase IV we could be on the verge of an uptick that would blow away USR**M's move last year. Many reasons can apply here. One they are on the verge of validation of their patented technology in stem cells which creates HUGE INTELLECTUAL VALUE IN THEIR TECHNOLOGY AND COMPANY. Believe me much higher than a market cap of 600,000 or even 25 million(USR**M). We could be pushing 100's of million's in worth from a market cap perspective. Also if I was a bio-tech company looking to buy out a company and was flush with cash I would most definitely trigger a sell off with notes due to LOAD THE BOAT BIGTIME. The stock has been pushed down from a 52 week high over .50 cents and more recently a few months ago at .25 cents. Our 200dma is in the .18 range. The 52 week low is .0021. We are ground floor here IMHO.

The SS is incredible last checked in the 400,940,232 O/S range. Nothingness considering the revenue potential.

One thing we do know as seasoned investors VOLUME AND DOLLARS INVESTED MEANS SOMETHING AND IN THIS CASE YOU CAN BET ITS GOOD!!!!

Definitely something to think about. I am not selling for pennies that's for sure!

We know larger Bio's and Pharma' are looking to add to their revenue streams and they are doing it via mergers/acquisitions.




Why 2018 Could Be An Explosive Year For Biotech Mergers

https://www.investors.com/news/technology/why-2018-could-be-an-explosive-year-for-biotech-mergers/

$11 billion biotech binge fuels forecasts of 2018 M&A surge

https://www.reuters.com/article/uk-biotech-m-a-analysis/11-billion-biotech-binge-fuels-forecasts-of-2018-ma-surge-idUSKBN1EX1KF

Why 2018 is a make-or-break year for pharma

Many drugmakers have neglected their pipelines, and will look to acquisitions to bolster them

https://www.marketwatch.com/story/why-2018-is-a-make-or-break-year-for-pharma-2017-12-19

Tax Overhaul Could Jolt Dollar as U.S. Companies Bring Home Cash

Corporations could repatriate as much as $400 billion in earnings and cash from abroad

https://www.wsj.com/articles/tax-overhaul-could-jolt-dollar-as-u-s-companies-bring-home-cash-1514206800

$CELZ